Research and Development 11 Lug 2023 Benefit from R&D Switzerland’s pragmatic collaboration between science and industry can help your company expedite the journey of your products to market. Learn h...
News 08 Mar 2023 Oculis lists on Nasdaq with strong clinical-stage pipeline in ophthalmology Oculis Holding AG, a global biopharmaceutical company focused on saving sight and improving eye care, has announced its listing on the Nasdaq sto...
News 28 Giu 2023 Innovative Western Switzeland start-ups take center stage in global awards Start-ups WattAnyWhere, Enhance-d, and Neur.on win big in global awards thanks to their pioneering technologies in cleantech, healthcare, and leg...
News 26 Apr 2023 Western Switzerland’s biotech sector flourishes amidst global challenges Western Switzerland's biotech industry continues to thrive, displaying resilience amidst global challenges. The region's unique ecosystem fosters...
News 14 Mar 2023 CSEM leads the industrialization of HiFiBiO’s complex microfluidic chips HiFiBiO Therapeutics and CSEM are collaborating to create and produce single-cell microfluidics, which have the potential to revolutionize immuno...
Actualités 06 Ott 2020 SOPHiA GENETICS lève 110 millions de dollars Leader mondial de la médecine basée sur les données, SOPHiA GENETICS a conclu un tour de financement de 110 millions de dollars pour entrer dans ...
News 16 Gen 2023 Geneva start-up STALICLA signs exclusive in-licensing agreement with Novartis STALICLA has acquired global rights for Novartis' drug candidate mavoglurant, a treatment for substance-use disorders and neurodevelopmental diso...
News 23 Nov 2022 Geneva biopharma ObsEva sells its Ebopiprant license for up to USD 113 million Women's and reproductive health specialist ObsEva has announced the sale of its license for ebopiprant to California-based biotech company Xoma f...
News 26 Mag 2023 UCB: "It's difficult to beat Swiss quality - even the Chinese admit as much." UCB UCB is a global biopharmaceutical company based in Belgium. Since 1996, it has invested more than 600 million Swiss francs in a state-of-the-art ...
News 13 Feb 2023 Hôpital de La Tour will invest CHF 750 million to create a health campus in Geneva Leading private healthcare facility Hôpital de la Tour has entered into a CHF 750 million agreement to create a major health campus project to pr...
News 25 Ott 2022 Artificial intelligence entering nutritional advice A system based on artificial intelligence can analyze pictures taken of meals and drinks. It was developed by digital health company Oviva togeth...
News 15 Nov 2022 Comet, Neuria and PMF-System win the Fribourg Innovation Award The canton of Fribourg has distinguished its most innovative companies. The Business Award went to Comet, the Start-up Award went to Neuria, and ...
News 07 Nov 2022 Idiap and InflamAlps partner up to accelerate antibiotic research using artificial intelligence The result of a partnership between Valais-based pharma company InflamAlps and the Idiap institute, the ABRoad project aims to accelerate the sel...